ArticleFrontiers in medicine2026
Cerebrospinal fluid glucose-to-lactate ratio (CGLR) as a diagnostic biomarker for postoperative intracranial infections in patients with acute brain injury: a prospective diagnostic accuracy study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this study was to evaluate the diagnostic accuracy of the cerebrospinal fluid glucose-to-lactate ratio (CGLR) for detecting postoperative intracranial infections in patients with acute brain injury (ABI) and compare it with conventional biomarkers. Methods: A single-center prospective study was conducted with 121 postoperative ABI patients suspected of infection. Cerebrospinal fluid (CSF) and peripheral blood samples were collected under aseptic conditions. Levels of CSF lactate (cLac), CSF glucose (cGlu), CSF procalcitonin (PCT), and CGLR were measured. Results: The AUC values for cGlu and cLac were 0.836 and 0.820, respectively, with optimal cutoffs of 2.6 mmol⋅L Conclusion: CGLR is a rapid, cost-effective, and reliable biomarker for diagnosing postoperative intracranial infections in ABI patients. It outperforms traditional markers and remains unaffected by peripheral glucose fluctuations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.